Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-26
2008-11-04
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000
Reexamination Certificate
active
07446127
ABSTRACT:
There are disclosed derivatives of 3-chromancarboxylic acid represented by formula Itheir pharmaceutically acceptable salts thereof and prodrugs thereof which are useful for treatment and control of non-insulin dependent diabetes mellitus (type II diabetes) and its related vascular disease as well as obesity and lipid disorders.
REFERENCES:
patent: 5639771 (1997-06-01), Obata et al.
patent: 06-32957 (1994-11-01), None
patent: WO 01/26656 (2001-04-01), None
Lei Tang, Juanhong Yu, Ying Leng, Ying Feng, Yushe Yang and Ruyun Ji, “Synthesis and Insulin-Sensitizing Activity of a Novel Kind of Benzopyran Derivative”, Bioorganic & Medicinal Chemistry Letters 13 (2003) 3437-3440.
R. J. Jarett, “Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease- chicken, egg or neither?”, Diabetologia, 1984, 26: 99-102.
Choi Yong Moon
Ilankumaran Palanichamy
Kim Hong Wook
Shin Hunwoo
Anderson Rebecca L
Havlin Robert
SK Holdings Co, Ltd.
LandOfFree
Chroman carboxylic acid derivatives for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chroman carboxylic acid derivatives for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chroman carboxylic acid derivatives for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4043849